Results of “fast track” clinical trial yield more live births and faster pregnancies. Researchers in New England published results of a major clinical trial that compared an accelerated treatment strategy for couples with unexplained infertility compared to a conventional approach using injectable gonadotropins. Results of the fast track and standard treatment trial (FASTT) indicate that the accelerated approach, which moved directly to in vitro fertilization (IVF) after three cycles of clomiphene/intrauterine insemination (IUI), resulted in a shorter time to pregnancy, more live births and lower costs. About the FASTT trial Couples who participated in the FASTT trial were randomly assigned to one of two

RMA of Philadelphia and sister practice RMA of Pennsylvania joined dozens of regional infertility leaders in Philadelphia’s most historic neighborhood late last month for the 6th annual Jefferson Infertility Counseling Conference. RMA had a big presence at the conference, which explores the psychological, legal and ethical issues surrounding fertility care. Members of the RMA team handed out materials on fertility treatments like Intrauterine Insemination (IUI) and In Vitro Fertilization (IVF) from the RMA booth, and RMA of Philadelphia's Dr. William Schlaff moderated a session on the latest innovations in fertility care. Dr. Schlaff, who also serves as the Department Chair of Obstetrics &

  Nearly 210,000 In Vitro Fertilization (IVF) cycles were performed in the US in 2015*. Over 5,000 of these cycles were carried out at Reproductive Medicine Associates (RMA) of New Jersey. IVF is a well-established and effective treatment option to help patients build their families. There are a variety of reasons for patients to undergo IVF, including age, blocked Fallopian tubes, male factor infertility, unexplained infertility, genetic disorders, chromosomal factors, ovulation problems, and endometriosis. Many assume that IVF increases their risk of multiple gestation (twins, triplets, etc.) compared to other fertility treatments like intrauterine insemination (IUI). This assumption is incorrect.  The key factor that

Recently announced results of a newly released IVF study shows that delaying embryonic screening for chromosomal abnormalities until the fifth day of development – the blastocyst stage – significantly improved implantation rates and led to more successful pregnancies. The study was published online in the June edition of Fertility & Sterility. While many IVF patients choose to have their embryos screened for chromosomal viability, testing has traditionally been conducted on day three, at the cleavage stage of development. Data from the new study shows that the practice of cleavage-stage biopsy can impair an embryo’s ability to implant and become a healthy